After their daughter was diagnosed with alternating hemiplegia of childhood (AHC), a rare and life-threatening neurological disorder, the Frost family partnered with Harvard scientists to advance groundbreaking gene-editing research that offers new hope for those affected by AHC and other rare diseases.